Authors:
HJORTH M
HOMBERG E
RODJER S
TURESSON I
WESTIN J
WISLOFF F
Citation: M. Hjorth et al., SURVIVAL IN CONVENTIONALLY TREATED YOUNGER (LESS-THAN-60 YEARS) MULTIPLE-MYELOMA PATIENTS - NO PROGRESS DURING 2 DECADES, British Journal of Haematology, 102(1), 1998, pp. 354-355
Authors:
BRINCKER H
WESTIN J
ABILDGAARD N
GIMSING P
TURESSON I
HEDENUS M
FORD J
KANDRA A
Citation: H. Brincker et al., FAILURE OF ORAL PAMIDRONATE TO REDUCE SKELETAL MORBIDITY IN MULTIPLE-MYELOMA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL, British Journal of Haematology, 101(2), 1998, pp. 280-286
Citation: E. Nord et al., COST-UTILITY ANALYSIS OF MELPHALAN PLUS PREDNISONE WITH OR WITHOUT INTERFERON-ALPHA-2B IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - RESULTS FROM ARANDOMIZED CONTROLLED TRIAL, PharmacoEconomics, 12(1), 1997, pp. 89-103
Citation: J. Westin et M. Lardelli, 3 NOVEL NOTCH GENES IN ZEBRAFISH - IMPLICATIONS FOR VERTEBRATE NOTCH GENE EVOLUTION AND FUNCTION, Development, genes and evolution, 207(1), 1997, pp. 51-63
Citation: Yq. Zheng et al., COMBINING GENETIC GAIN AND DIVERSITY BY CONSIDERING AVERAGE COANCESTRY IN CLONAL SELECTION OF NORWAY SPRUCE, Theoretical and Applied Genetics, 95(8), 1997, pp. 1312-1319
Authors:
THUNBERG U
BANGHAGEN M
THURESSON B
WESTIN J
SWEDIN A
LENHOFF S
OLOFSSON T
GEISLER C
GIMSING P
ANDERSEN NS
MORTENSEN BT
SIMONSEN AC
BENGTSSON M
SALLSTROM JF
SIMONSSON B
CARLSON K
Citation: U. Thunberg et al., PRESENCE OF CLONAL CELLS IN ALL STEM-CELL ENRICHED GRAFTS IN TRANSPLANTED MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 959-959
Authors:
GULLBERG U
SVEDBERG H
RAUSCHER FJ
CHYLICKI K
WESTIN J
Citation: U. Gullberg et al., OVEREXPRESSION OF THE WILMS-TUMOR GENE (WT1) IN THE LEUKEMIC-CELL LINE U937 BLOCKS PARTS OF THE DIFFERENTIATION PROGRAM, Blood, 90(10), 1997, pp. 2172-2172
Authors:
HJORTH M
HOLMBERG E
RODJER S
TAUBE A
WESTIN J
Citation: M. Hjorth et al., PHYSICIANS ATTITUDES TOWARD CLINICAL-TRIALS AND THEIR RELATIONSHIP TOPATIENT ACCRUAL IN A NORDIC MULTICENTER STUDY ON MYELOMA, Controlled clinical trials, 17(5), 1996, pp. 372-386
Authors:
MALMSTEN M
LASSEN B
WESTIN J
GOLANDER CG
LARSSON R
NILSSON UR
Citation: M. Malmsten et al., ADSORPTION OF COMPLEMENT PROTEIN C3 AT POLYMER SURFACES, Journal of colloid and interface science, 179(1), 1996, pp. 163-172
Citation: F. Wisloff et al., EFFECT OF INTERFERON ON THE HEALTH-RELATED QUALITY-OF-LIFE OF MULTIPLE-MYELOMA PATIENTS - RESULTS OF A NORDIC RANDOMIZED TRIAL COMPARING MELPHALAN-PREDNISONE TO MELPHALAN-PREDNISONE PLUS ALPHA-INTERFERON, British Journal of Haematology, 94(2), 1996, pp. 324-332
Authors:
WISLOFF F
EIKA S
HIPPE E
HJORTH M
HOLMBERG E
KAASA S
PALVA I
WESTIN J
Citation: F. Wisloff et al., MEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN MULTIPLE-MYELOMA, British Journal of Haematology, 92(3), 1996, pp. 604-613
Authors:
HJORTH M
WESTIN J
DAHL IMS
GIMSING P
HIPPE E
HOLMBERG E
LAMVIK J
NIELSEN JL
LOFVENBERG E
PALVA IP
RODJER S
TALSTAD I
TURESSON I
WISLOFF F
ZADOR G
AMSLERNORDIN S
POLGARY M
ODEN A
WALLGREN A
WILHELMSEN L
HELLQVIST L
HASSELBLOM S
CARNESKOG J
LINDQVIST O
HOFFMAN P
OLSSON K
THOLEN A
STOLT CM
RINDNER A
SVENSSON R
VAART J
HANSEN S
ENGQVIST L
LANNEMYR O
NILSSON PG
LINNE I
LILJA G
TALLROTH G
HALLGREN J
ANDERSSON B
BILLSTROM R
PERSSON S
SAMUELSSON T
ODEBERG H
ADRIANSSON M
TOVE H
STOBEUS N
HABBERSTAD J
END T
DAHLEN M
ERIKSSON M
ANAGRIUS N
ARONSON D
NEZADAL L
ERIKSSON K
HEDENUS M
RYDE J
WESTIN L
ANDERSSON LO
BJURMAN A
FORSBERG K
FORS D
WIKSTROM S
THULE B
BOLSOY U
LENNERMO K
STRAND T
PALVA I
ALMQVIST A
ISOMAA B
OKSANEN K
EIKA C
LY B
BRANDT E
WEYDE K
FOSSUM C
LOVASEN K
SPARBY JA
JACOBSEN EM
RINDE M
NYHUS S
KAHRS J
STEEN T
GRAVDAHL H
BORGE L
GROTTUM KA
FLOTTEROD O
STROM BR
KNUTSEN H
DRIVENES A
PAULSEN J
RIIS S
HAUGE PW
NESTHUS I
COLL P
HOLE KH
SAETER T
SINDRE T
BERENTSEN S
NES H
VAGSTAD G
HEIKKELA R
SHAMMAS V
LODEMEL B
SKOGEN OR
SORUM Y
KVAMBE V
BULL O
JAEGER S
INGVALDSEN PG
PEDERSEN K
HANSEN LT
ONKIEHONG M
HAUGNES T
STEFANSEN D
GADEBERG O
ABILDGAARD N
JANS H
MOURITSANDERSEN T
NEUBAUER B
CLAUSEN NT
MAGNUSSON S
EYJOLFSSON G
BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
Authors:
WALLERSTEDT S
DENISON H
SANDSTROM J
WESTIN J
Citation: S. Wallerstedt et al., THE PREVALENCE OF ALCOHOLISM AND ITS RELATION TO CAUSE OF HOSPITALIZATION AND LONG-TERM MORTALITY IN MALE SOMATIC INPATIENTS, Journal of internal medicine, 237(3), 1995, pp. 339-344
Citation: H. Nilssonehle et al., BONE-MARROW PROGENITOR-CELL GROWTH AND KARYOTYPE CHANGES IN HEALTHY 88-YEAR-OLD SUBJECTS, European journal of haematology, 55(1), 1995, pp. 14-18
Citation: J. Westin et al., SEASONAL-VARIATION IN PHOTOCHEMICAL ACTIVITY AND HARDINESS IN CLONES OF NORWAY SPRUCE (PICEA-ABIES), Tree physiology, 15(10), 1995, pp. 685-689
Citation: B. Silverin et J. Westin, INFLUENCE OF THE OPPOSITE SEX ON PHOTOPERIODICALLY INDUCED LH AND GONADAL CYCLES IN THE WILLOW TIT (PARUS-MONTANUS), Hormones and behavior, 29(2), 1995, pp. 207-215
Authors:
HJORTH M
HOLMBERG E
RODJER S
TAUBE A
WESTIN J
Citation: M. Hjorth et al., PATIENT ACCRUAL AND QUALITY OF PARTICIPATION IN A MULTICENTER STUDY ON MYELOMA - A COMPARISON BETWEEN MAJOR AND MINOR PARTICIPATING CENTERS, British Journal of Haematology, 91(1), 1995, pp. 109-115
Authors:
WESTIN J
RODJER S
TURESSON I
CORTELEZZI A
HJORTH M
ZADOR G
Citation: J. Westin et al., INTERFERON ALFA-2B VERSUS NO MAINTENANCE THERAPY DURING THE PLATEAU-PHASE IN MULTIPLE-MYELOMA - A RANDOMIZED STUDY, British Journal of Haematology, 89(3), 1995, pp. 561-568
Citation: J. Westin, INTERFERON-ALFA-2B IN ADDITION TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE TREATMENT IN MULTIPLE-MYELOMA - A RANDOMIZED NORDIC TRIAL, Blood, 86(10), 1995, pp. 1751-1751
Authors:
KNUDSEN LM
HIPPE E
HJORTH M
HOLMBERG E
WESTIN J
Citation: Lm. Knudsen et al., RENAL-FUNCTION IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - A DEMOGRAPHIC-STUDY OF 1353 PATIENTS, European journal of haematology, 53(4), 1994, pp. 207-212
Citation: A. Weinfeld et al., ACUTE-LEUKEMIA AFTER HYDROXYUREA THERAPY IN POLYCYTHEMIA-VERA AND ALLIED DISORDERS - PROSPECTIVE-STUDY OF EFFICACY AND LEUKAEMOGENICITY WITH THERAPEUTIC IMPLICATIONS, European journal of haematology, 52(3), 1994, pp. 134-139
Authors:
SIMONSSON B
OBERG G
KILLANDER A
BJOREMAN M
BJORKHOLM M
GAHRTON G
STENKE L
TURESSON I
UDEN AM
MALM C
VILEN L
WAHLIN A
LOFVENBERG E
CARNESKOG J
WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML), Bone marrow transplantation, 14, 1994, pp. 55-56
Authors:
SIMONSSON B
OBERG G
KILLANDER A
BJOREMAN M
BJORKHOLM M
GAHRTON G
HAST R
TURESSON I
UDEN AM
MALM C
VILEN L
WAHLIN A
LOFVENBERG E
CARNESKOG J
WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA, Stem cells, 11, 1993, pp. 73-76
Citation: H. Back et al., SERUM DEOXYTHYMIDINE KINASE - NO HELP IN THE DIAGNOSIS AND PROGNOSIS OF MONOCLONAL GAMMOPATHY, British Journal of Haematology, 84(4), 1993, pp. 746-748